{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T07:55:09Z","timestamp":1777622109285,"version":"3.51.4"},"reference-count":65,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T00:00:00Z","timestamp":1760486400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100020595","name":"National Science and Technology Council","doi-asserted-by":"publisher","award":["NSTC113\\u20132314-B-214\\u2013002"],"award-info":[{"award-number":["NSTC113\\u20132314-B-214\\u2013002"]}],"id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020595","name":"National Science and Technology Council","doi-asserted-by":"publisher","award":["NSTC113\\u20132320-B-037\\u2013011-MY3"],"award-info":[{"award-number":["NSTC113\\u20132320-B-037\\u2013011-MY3"]}],"id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020595","name":"National Science and Technology Council","doi-asserted-by":"publisher","award":["NSTC114\\u20132735-B-001\\u2013001"],"award-info":[{"award-number":["NSTC114\\u20132735-B-001\\u2013001"]}],"id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004694","name":"Kaohsiung Medical University","doi-asserted-by":"publisher","award":["KMU-TB114008"],"award-info":[{"award-number":["KMU-TB114008"]}],"id":[{"id":"10.13039\/501100004694","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004694","name":"Kaohsiung Medical University","doi-asserted-by":"publisher","award":["KMU-TC114A08"],"award-info":[{"award-number":["KMU-TC114A08"]}],"id":[{"id":"10.13039\/501100004694","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jbc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Biological Chemistry"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.jbc.2025.110831","type":"journal-article","created":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T22:32:50Z","timestamp":1760653970000},"page":"110831","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Structural and molecular dynamics insights into the competitive inhibition of the platelet-activating factor receptor by acyl-PAF"],"prefix":"10.1016","volume":"301","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-6241-8283","authenticated-orcid":false,"given":"Shao-Chi","family":"Hung","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chih-Chieh","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7016-8392","authenticated-orcid":false,"given":"Hua-Chen","family":"Chan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mei-Lin","family":"Chan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"You Shan","family":"Ngui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jia-Bin","family":"Mei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi-Wen","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vyala Hanumanthareddy","family":"Chaithra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gopal Kedihithlu","family":"Marathe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2547-0987","authenticated-orcid":false,"given":"Liang-Yin","family":"Ke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jbc.2025.110831_bib1","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1038\/269170a0","article-title":"Structural analysis of purified platelet-activating factor by lipases","volume":"269","author":"Benveniste","year":"1977","journal-title":"Nature"},{"key":"10.1016\/j.jbc.2025.110831_bib2","doi-asserted-by":"crossref","first-page":"9355","DOI":"10.1016\/S0021-9258(19)83523-8","article-title":"Platelet-activating factor. Evidence for 1-O-alkyl-2-acetyl-sn-glyceryl-3-phosphorylcholine as the active component (a new class of lipid chemical mediators","volume":"254","author":"Demopoulos","year":"1979","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jbc.2025.110831_bib3","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.4049\/jimmunol.129.4.1637","article-title":"Specific binding of phospholipid platelet-activating factor by human platelets","volume":"129","author":"Valone","year":"1982","journal-title":"J. Immunol."},{"key":"10.1016\/j.jbc.2025.110831_bib4","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1111\/1755-5922.12233","article-title":"Platelet activating factor: a potential biomarker in acute coronary syndrome?","volume":"35","author":"Palur Ramakrishnan","year":"2017","journal-title":"Cardiovasc. Ther."},{"key":"10.1016\/j.jbc.2025.110831_bib5","doi-asserted-by":"crossref","first-page":"3632","DOI":"10.1182\/blood-2013-05-504639","article-title":"Highly electronegative LDL from patients with ST-elevation myocardial infarction triggers platelet activation and aggregation","volume":"122","author":"Chan","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.jbc.2025.110831_bib6","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1007\/s10753-007-9056-9","article-title":"Platelet activating factor as a mediator and therapeutic approach in bronchial asthma","volume":"31","author":"Kasperska-Zajac","year":"2008","journal-title":"Inflammation"},{"key":"10.1016\/j.jbc.2025.110831_bib7","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1016\/j.jaci.2015.04.019","article-title":"Platelets in the immune response: revisiting platelet-activating factor in anaphylaxis","volume":"135","author":"Gill","year":"2015","journal-title":"J. Allergy. Clin. Immunol."},{"key":"10.1016\/j.jbc.2025.110831_bib8","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/j.biochi.2010.02.011","article-title":"The platelet activating factor (PAF) signaling cascade in systemic inflammatory responses","volume":"92","author":"Yost","year":"2010","journal-title":"Biochimie"},{"key":"10.1016\/j.jbc.2025.110831_bib9","first-page":"10","article-title":"Impact of targeting the platelet-activating factor and its receptor in cancer treatment","volume":"12","author":"Qaderi","year":"2025","journal-title":"Mil. Med. Res."},{"key":"10.1016\/j.jbc.2025.110831_bib10","doi-asserted-by":"crossref","first-page":"C697","DOI":"10.1152\/ajpcell.1990.259.5.C697","article-title":"Platelet-activating factor and related acetylated lipids as potent biologically active cellular mediators","volume":"259","author":"Snyder","year":"1990","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.jbc.2025.110831_bib11","doi-asserted-by":"crossref","first-page":"6532","DOI":"10.1074\/jbc.M609641200","article-title":"A single enzyme catalyzes both platelet-activating factor production and membrane biogenesis of inflammatory cells. Cloning Characterization Acetyl-coa:lyso-paf Acetyltransferase","volume":"282","author":"Shindou","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jbc.2025.110831_bib12","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.prostaglandins.2015.09.001","article-title":"Platelet activating factor (PAF) biosynthesis is inhibited by phenolic compounds in U-937 cells under inflammatory conditions","volume":"121","author":"Vlachogianni","year":"2015","journal-title":"Prostaglandins. Other. Lipid. Mediat."},{"key":"10.1016\/j.jbc.2025.110831_bib13","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1038\/349342a0","article-title":"Cloning by functional expression of platelet-activating factor receptor from guinea-pig lung","volume":"349","author":"Honda","year":"1991","journal-title":"Nature"},{"key":"10.1016\/j.jbc.2025.110831_bib14","doi-asserted-by":"crossref","first-page":"3242","DOI":"10.4049\/jimmunol.177.5.3242","article-title":"Activation and regulation of platelet-activating factor receptor: role of G(i) and G(q) in receptor-mediated chemotactic, cytotoxic, and cross-regulatory signals","volume":"177","author":"Brown","year":"2006","journal-title":"J. Immunol."},{"key":"10.1016\/j.jbc.2025.110831_bib15","first-page":"4414","article-title":"Forty years since the structural elucidation of platelet-activating factor (PAF): historical","volume":"24","author":"Lordan","year":"2019","journal-title":"Curr. Future. Res. Perspect. Mol."},{"key":"10.1016\/j.jbc.2025.110831_bib16","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1002\/art.41213","article-title":"Role of low-density lipoprotein in early vascular aging associated with systemic Lupus Erythematosus","volume":"72","author":"Chan","year":"2020","journal-title":"Arthritis. Rheumatol."},{"key":"10.1016\/j.jbc.2025.110831_bib17","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/0006-291X(87)91338-6","article-title":"Evidence for existence of various homologues and analogues of platelet activating factor in a lipid extract of bovine brain","volume":"145","author":"Tokumura","year":"1987","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.jbc.2025.110831_bib18","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1016\/0006-291X(91)90465-J","article-title":"Synthesis of 1-acyl-2-[3H]acetyl-SN-glycero-3-phosphocholine, a structural analog of platelet activating factor, by vascular endothelial cells","volume":"176","author":"Mueller","year":"1991","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.jbc.2025.110831_bib19","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1194\/jlr.M200292-JLR200","article-title":"Modulation by flavonoids of PAF and related phospholipids in endothelial cells during oxidative stress","volume":"44","author":"Balestrieri","year":"2003","journal-title":"J. Lipid. Res."},{"key":"10.1016\/j.jbc.2025.110831_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.prostaglandins.2020.106478","article-title":"Effect of acyl and alkyl analogs of platelet-activating factor on inflammatory signaling","volume":"151","author":"Marathe","year":"2020","journal-title":"Prostaglandins. Other. Lipid. Mediat."},{"issue":"Pt 2","key":"10.1016\/j.jbc.2025.110831_bib21","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1042\/bj2860497","article-title":"Factors that influence the proportions of platelet-activating factor and 1-acyl-2-acetyl-sn-glycero-3-phosphocholine synthesized by the mast cell","volume":"286","author":"Triggiani","year":"1992","journal-title":"Biochem. J."},{"key":"10.1016\/j.jbc.2025.110831_bib22","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1194\/jlr.M085704","article-title":"Modulation of inflammatory platelet-activating factor (PAF) receptor by the acyl analogue of PAF","volume":"59","author":"Chaithra","year":"2018","journal-title":"J. Lipid. Res."},{"key":"10.1016\/j.jbc.2025.110831_bib23","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1016\/j.neuron.2018.08.011","article-title":"Molecular dynamics simulation for All","volume":"99","author":"Hollingsworth","year":"2018","journal-title":"Neuron"},{"key":"10.1016\/j.jbc.2025.110831_bib24","doi-asserted-by":"crossref","DOI":"10.1063\/5.0018516","article-title":"Heterogeneous parallelization and acceleration of molecular dynamics simulations in GROMACS","volume":"153","author":"Pall","year":"2020","journal-title":"J. Chem. Phys."},{"key":"10.1016\/j.jbc.2025.110831_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2024.114422","article-title":"Molecular basis for the activation of PAF receptor by PAF","volume":"43","author":"Fan","year":"2024","journal-title":"Cell. Rep."},{"key":"10.1016\/j.jbc.2025.110831_bib26","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1152\/physrev.2000.80.4.1669","article-title":"Role of platelet-activating factor in cardiovascular pathophysiology","volume":"80","author":"Montrucchio","year":"2000","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.jbc.2025.110831_bib27","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1021\/acs.chemrev.6b00177","article-title":"GPCR dynamics: structures in motion","volume":"117","author":"Latorraca","year":"2017","journal-title":"Chem. Rev."},{"key":"10.1016\/j.jbc.2025.110831_bib28","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1074\/jbc.M113.493643","article-title":"Dissociated G\u03b1GTP and G\u03b2\u03b3 protein subunits are the major activated form of heterotrimeric Gi\/o proteins","volume":"289","author":"Bondar","year":"2014","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jbc.2025.110831_bib29","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1002\/biof.1883","article-title":"Platelet activating factor (PAF): a mediator of inflammation","volume":"48","author":"Upton","year":"2022","journal-title":"Biofactors"},{"key":"10.1016\/j.jbc.2025.110831_bib30","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1021\/acsptsci.0c00012","article-title":"Perspective: implications of ligand-receptor binding kinetics for therapeutic targeting of G protein-coupled receptors","volume":"3","author":"van der Velden","year":"2020","journal-title":"ACS. Pharmacol. Transl. Sci."},{"key":"10.1016\/j.jbc.2025.110831_bib31","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/nature09648","article-title":"Structure of a nanobody-stabilized active state of the \u03b2(2) adrenoceptor","volume":"469","author":"Rasmussen","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.jbc.2025.110831_bib32","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1038\/nature23272","article-title":"Crystal structures of agonist-bound human cannabinoid receptor CB(1","volume":"547","author":"Hua","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.jbc.2025.110831_bib33","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1038\/s41594-018-0068-y","article-title":"Structural basis for signal recognition and transduction by platelet-activating-factor receptor","volume":"25","author":"Cao","year":"2018","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.jbc.2025.110831_bib34","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1038\/nchembio.385","article-title":"Structural basis of G protein-coupled receptor-G protein interactions","volume":"6","author":"Hu","year":"2010","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.jbc.2025.110831_bib35","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.sbi.2016.11.005","article-title":"Mechanistic insights into GPCR-G protein interactions","volume":"41","author":"Mahoney","year":"2016","journal-title":"Curr. Opin. Struct. Biol."},{"key":"10.1016\/j.jbc.2025.110831_bib36","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.fitote.2012.11.002","article-title":"Platelet-activating factor (PAF)-antagonists of natural origin","volume":"84","author":"Singh","year":"2013","journal-title":"Fitoterapia"},{"key":"10.1016\/j.jbc.2025.110831_bib37","series-title":"Biochemistry of Platelet Activating Factor in StatPearls, StatPearls Publishing Copyright 2025","author":"Ashraf","year":"2025"},{"key":"10.1016\/j.jbc.2025.110831_bib38","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/0090-6980(92)90061-W","article-title":"Relative amounts of 1-O-alkyl- and 1-acyl-2-acetyl-sn-glycero-3-phosphocholine in stimulated endothelial cells","volume":"43","author":"Whatley","year":"1992","journal-title":"Prostaglandins"},{"key":"10.1016\/j.jbc.2025.110831_bib39","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1038\/374549a0","article-title":"Anti-inflammatory properties of a platelet-activating factor acetylhydrolase","volume":"374","author":"Tjoelker","year":"1995","journal-title":"Nature"},{"key":"10.1016\/j.jbc.2025.110831_bib40","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s10557-008-6133-8","article-title":"Biology of platelet-activating factor acetylhydrolase (PAF-AH, lipoprotein associated phospholipase A2)","volume":"23","author":"Stafforini","year":"2009","journal-title":"Cardiovasc. Drugs. Ther."},{"key":"10.1016\/j.jbc.2025.110831_bib41","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.3390\/ijms20051149","article-title":"An updated review of lysophosphatidylcholine metabolism in human diseases","volume":"20","author":"Law","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jbc.2025.110831_bib42","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/S0022-2275(20)38359-0","article-title":"Hydrolysis of phosphatidylcholine during LDL oxidation is mediated by platelet-activating factor acetylhydrolase","volume":"30","author":"Steinbrecher","year":"1989","journal-title":"J. Lipid. Res."},{"key":"10.1016\/j.jbc.2025.110831_bib43","doi-asserted-by":"crossref","first-page":"28395","DOI":"10.1074\/jbc.274.40.28395","article-title":"Inflammatory platelet-activating factor-like phospholipids in oxidized low density lipoproteins are fragmented alkyl phosphatidylcholines","volume":"274","author":"Marathe","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jbc.2025.110831_bib44","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2102953118","article-title":"Lipoprotein-associated phospholipase A(2): a paradigm for allosteric regulation by membranes","volume":"119","author":"Mouchlis","year":"2022","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jbc.2025.110831_bib45","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1194\/jlr.R045492","article-title":"To hydrolyze or not to hydrolyze: the dilemma of platelet-activating factor acetylhydrolase","volume":"55","author":"Marathe","year":"2014","journal-title":"J. Lipid. Res."},{"key":"10.1016\/j.jbc.2025.110831_bib46","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1373\/clinchem.2011.180281","article-title":"Relationship of lipoprotein-associated phospholipase A2 mass and activity with incident vascular events among primary prevention patients allocated to placebo or to statin therapy: an analysis from the JUPITER trial","volume":"58","author":"Ridker","year":"2012","journal-title":"Clin. Chem."},{"key":"10.1016\/j.jbc.2025.110831_bib47","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0048171","article-title":"Lipoprotein-associated phospholipase A2 activity predicts cardiovascular events in high risk coronary artery disease patients","volume":"7","author":"Maiolino","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.jbc.2025.110831_bib48","first-page":"659","article-title":"Lipoprotein associated phospholipase A2 concentration predicts total and cardiovascular mortality independently of established risk factors (the ludwigshafen risk and cardiovascular health study)","volume":"57","author":"Kleber","year":"2011","journal-title":"Clin. Lab."},{"key":"10.1016\/j.jbc.2025.110831_bib49","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1016\/S0140-6736(10)60319-4","article-title":"Lipoprotein-associated phospholipase A(2) and risk of coronary disease, stroke, and mortality: collaborative analysis of 32 prospective studies","volume":"375","author":"Thompson","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.jbc.2025.110831_bib50","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1056\/NEJMoa1315878","article-title":"Darapladib for preventing ischemic events in stable coronary heart disease","volume":"370","author":"White","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jbc.2025.110831_bib51","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1194\/jlr.E052886","article-title":"Unraveling the PAF-AH\/Lp-PLA2 controversy","volume":"55","author":"Stafforini","year":"2014","journal-title":"J. Lipid. Res."},{"key":"10.1016\/j.jbc.2025.110831_bib52","doi-asserted-by":"crossref","first-page":"6","DOI":"10.5339\/gcsp.2015.6","article-title":"STABILITY and SOLID-TIMI 52: Lipoprotein associated phospholipase A2 (Lp-PLA2) as a biomarker or risk factor for cardiovascular diseases","volume":"2015","author":"Hassan","year":"2015","journal-title":"Glob. Cardiol. Sci. Pract."},{"key":"10.1016\/j.jbc.2025.110831_bib53","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1097\/01.CCM.0000063267.79824.DB","article-title":"Recombinant platelet-activating factor acetylhydrolase to prevent acute respiratory distress syndrome and mortality in severe sepsis: phase IIb, multicenter, randomized, placebo-controlled, clinical trial","volume":"31","author":"Schuster","year":"2003","journal-title":"Crit. Care. Med."},{"key":"10.1016\/j.jbc.2025.110831_bib54","doi-asserted-by":"crossref","first-page":"4414","DOI":"10.3390\/nu14204414","article-title":"Targeting the platelet-activating factor receptor (PAF-R): antithrombotic and anti-atherosclerotic Nutrients","volume":"14","author":"Harishkumar","year":"2022","journal-title":"Nutrients"},{"key":"10.1016\/j.jbc.2025.110831_bib55","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1002\/jcc.20945","article-title":"CHARMM-GUI: a web-based graphical user interface for CHARMM","volume":"29","author":"Jo","year":"2008","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.jbc.2025.110831_bib56","doi-asserted-by":"crossref","first-page":"3891","DOI":"10.1021\/acs.jcim.1c00203","article-title":"AutoDock vina 1.2.0: new docking methods, expanded force field, python bindings","volume":"61","author":"Eberhardt","year":"2021","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.jbc.2025.110831_bib57","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/1758-2946-3-33","article-title":"Open babel: an open chemical toolbox","volume":"3","author":"O'Boyle","year":"2011","journal-title":"J. Cheminform."},{"key":"10.1016\/j.jbc.2025.110831_bib58","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1002\/jcc.21367","article-title":"CHARMM general force field: a force field for drug-like molecules compatible with the CHARMM all-atom additive biological force fields","volume":"31","author":"Vanommeslaeghe","year":"2010","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.jbc.2025.110831_bib59","doi-asserted-by":"crossref","first-page":"5525","DOI":"10.1021\/acs.jctc.5b00743","article-title":"PyEMMA 2: a software package for estimation, validation, and analysis of markov models","volume":"11","author":"Scherer","year":"2015","journal-title":"J. Chem. Theor. Comput."},{"key":"10.1016\/j.jbc.2025.110831_bib60","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/0090-6980(92)90061-W","article-title":"Relative amounts of 1-O-alkyl-and 1-acyl-2-acetyl-sn-glycero-3-phosphocholine in stimulated endothelial cells","volume":"43","author":"Whatley","year":"1992","journal-title":"Prostaglandins"},{"key":"10.1016\/j.jbc.2025.110831_bib61","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1042\/bj2860497","article-title":"Factors that influence the proportions of platelet-activating factor and 1-acyl-2-acetyl-sn-glycero-3-phosphocholine synthesized by the mast cell","volume":"286","author":"Triggiani","year":"1992","journal-title":"Biochem. J."},{"key":"10.1016\/j.jbc.2025.110831_bib62","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1038\/289312a0","article-title":"Biosynthetic labelling of platelet activating factor from radioactive acetate by stimulated platelets","volume":"289","author":"Chap","year":"1981","journal-title":"Nature"},{"key":"10.1016\/j.jbc.2025.110831_bib63","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/S1044-0305(99)00135-X","article-title":"Mass spectrometric analysis of platelet-activating factor after isolation by solid-phase extraction and direct derivatization with pentafluorobenzoic anhydride","volume":"11","author":"Weintraub","year":"2000","journal-title":"J Am Soc Mass Spectrom"},{"key":"10.1016\/j.jbc.2025.110831_bib64","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/0006-291X(87)91338-6","article-title":"Evidence for existence of various homologues and analogues of platelet activating factor in a lipid extract of bovine brain","volume":"145","author":"Tokumura","year":"1987","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.jbc.2025.110831_bib65","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S0022-2275(20)38382-6","article-title":"Novel molecular analogues of phosphatidylcholines in a lipid extract from bovine brain: 1-long-chain acyl-2-short-chain acyl-sn-glycero-3-phosphocholines","volume":"30","author":"Tokumura","year":"1989","journal-title":"J Lipid Res"}],"container-title":["Journal of Biological Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925825026833?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925825026833?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T22:02:02Z","timestamp":1777413722000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021925825026833"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":65,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["S0021925825026833"],"URL":"https:\/\/doi.org\/10.1016\/j.jbc.2025.110831","relation":{},"ISSN":["0021-9258"],"issn-type":[{"value":"0021-9258","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Structural and molecular dynamics insights into the competitive inhibition of the platelet-activating factor receptor by acyl-PAF","name":"articletitle","label":"Article Title"},{"value":"Journal of Biological Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jbc.2025.110831","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc on behalf of American Society for Biochemistry and Molecular Biology\u00e9","name":"copyright","label":"Copyright"}],"article-number":"110831"}}